p-Tau217 Blood Screening

Blood-based p-Tau217 biomarker simulator for Alzheimer's screening pathways

Current Stage
—
—
Screening result
—
Pathology correlation
—
Age-adjusted risk
—
Follow-up
—
Plasma p-Tau217 level (rel. units)50
Patient age (years)65
Blood draw / plasma sample
p-Tau217 biomarker particles
Brain tau/amyloid pathology
PET / CSF reference signal
Positive threshold line
Scroll for details